Chinese biopharmaceutical company Sinovac Biotech claimed on Thursday that clinical trials for its potential COVID-19 vaccine will begin on teenagers and children at the end of the month, after drawing positive findings on adults.
Chinese biopharmaceutical company Sinovac Biotech claimed on Thursday that clinical trials for its potential COVID-19 vaccine will begin on teenagers and children at the end of the month, after drawing positive findings on adults.